Stocks · Healthcare · Biotechnology
Kymera Therapeutics, Inc. KYMR
$109.85 +2.29% Close, Oct 5, 2026 · NASDAQ · Market cap $8.83B
Strong growthStrong trend
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $105.0M, up 134.8% from a year earlier, accelerating from -12.6% a quarter earlier.
- Operating margin widened to -333.5% from -697.5% a year earlier.
- The diluted share count rose 22.0% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 8%
- Revenue growth, 3-year CAGRBottom 14%
- Revenue growth accelerationTop 2%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 49%
- Gross marginTop 1%
- Operating marginBottom 20%
- Accruals (lower is better)Bottom 33%
- Interest coverBottom 5%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 38%
- Free-cash-flow yieldTop 45%
- EBITDA / enterprise valueTop 47%
- Sales / enterprise valueBottom 9%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 15%
- 6-month returnTop 34%
- 1-year return vs S&P 500Top 16%
- Distance from 52-week highTop 26%
- Trend checklist (0–4)Top 43%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 35%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 29%
- Upside to consensus price targetBottom 34%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 22%
- Maximum drawdown, 3 yearsTop 35%
- Beta vs S&P 500 (lower is better)Bottom 19%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -12.6% | 134.8% | ↑ |
| Gross margin | 95.3% | 102.0% | ↑ |
| Operating margin | -697.5% | -333.5% | ↑ |
| FCF margin | -565.7% | -226.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 134.8% | -12.6% | ↑ | Top 8% |
| Gross margin | 102.0% | 95.3% | ↑ | Top 1% |
| Operating margin | -333.5% | -697.5% | ↑ | Bottom 20% |
| Net margin | -285.4% | -616.0% | ↑ | — |
| Free-cash-flow margin | -226.6% | -565.7% | ↑ | — |
| Return on invested capital | -22.1% | — | Bottom 49% | |
| Revenue growth, 3-year CAGR | -5.8% | — | Bottom 14% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 62.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -184.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -1659.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -8.37%
- Shareholder yield
- -8.37%
- Share count change, 1 year
- +22.0%
- Share count change, 3-year CAGR
- +19.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -4.3%
- Average 2-day reaction, last 8
- -2.7%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $138.07
- Target vs current price
- +25.7%
- Analysts with a rating
- 27
- Share rating Buy or Strong Buy
- 89%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +13.0% | +1.0% | +5.0% | +14.0% | — |
| Apr 30, 2026 | +20.2% | -0.5% | +5.8% | -0.1% | +35.0% |
| Feb 26, 2026 | -23.8% | +4.8% | -5.0% | -13.0% | -11.1% |
| Nov 4, 2025 | -26.8% | +0.3% | +2.6% | +7.6% | +21.7% |
| Aug 11, 2025 | -14.5% | -7.2% | +4.9% | +6.5% | +47.0% |
| May 9, 2025 | +10.9% | -2.3% | -2.4% | +54.8% | +39.6% |
| Feb 27, 2025 | -15.8% | -14.5% | -10.4% | -14.1% | -14.7% |
| Oct 31, 2024 | +1.2% | -3.1% | +3.8% | -1.7% | -17.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.62 | -$0.71 | +13.0% | $65.0M |
| Apr 30, 2026 | -$0.71 | -$0.89 | +20.2% | $34.4M |
| Feb 26, 2026 | -$0.97 | -$0.78 | -23.8% | $2.9M |
| Nov 4, 2025 | -$0.90 | -$0.71 | -26.8% | $2.8M |
| Aug 11, 2025 | -$0.95 | -$0.83 | -14.5% | $11.5M |
| May 9, 2025 | -$0.82 | -$0.92 | +10.9% | $22.1M |
| Feb 27, 2025 | -$0.88 | -$0.76 | -15.8% | $7.4M |
| Oct 31, 2024 | -$0.82 | -$0.83 | +1.2% | $3.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 83.74× | — | — | Bottom 9% |
| Free-cash-flow yield | -2.69% | — | — | Top 45% |
| Earnings yield | -2.96% | — | — | Top 38% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 289
- 50-day average slope (20 days)
- +0.4%
- 200-day average slope (20 days)
- +4.6%
- Distance from 50-day average
- -4.0%
- Distance from 200-day average
- +17.9%
- RSI (14)
- 42.0
- Relative volume
- 0.93×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 39.9%
- Volatility vs own 5-year history
- 2th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.82
- Correlation with S&P 500
- 0.38
- Current drawdown from 1-year high
- -13.7%
- Maximum drawdown, 3 years
- -59.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 28, 2020 | Oct 27, 2023 | -87.5% | 713 days | 529 days (Dec 8, 2025) |
| Dec 8, 2025 | Jan 20, 2026 | -27.7% | 28 days | 26 days (Feb 26, 2026) |
| Feb 26, 2026 | Jun 2, 2026 | -25.0% | 66 days | 13 days (Jun 22, 2026) |
| Jul 10, 2026 | Aug 3, 2026 | -16.0% | 16 days | 10 days (Aug 17, 2026) |
| Aug 19, 2026 | Oct 2, 2026 | -15.7% | 31 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $8.83B
- EPS, diluted (TTM)
- -$3.25
- Revenue (TTM)
- $105.0M
- 52-week range
- $55.26 – $130.05
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $72.8M | $46.8M | $78.6M | $47.1M | $39.2M |
| Gross profit | $72.8M | $46.8M | $78.6M | $47.1M | $39.2M |
| Operating income | -$100.5M | -$161.3M | -$165.5M | -$261.6M | -$349.4M |
| Net income | -$100.2M | -$154.8M | -$147.0M | -$223.9M | -$311.4M |
| EPS (diluted) | -$2.09 | -$2.87 | -$2.52 | -$2.98 | -$3.69 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7M | $7.4M | $22.1M | $11.5M | $2.8M | $2.9M | $34.4M | $65.0M |
| Net income | -$62.5M | -$70.8M | -$65.6M | -$76.6M | -$82.2M | -$87.0M | -$69.2M | -$61.2M |
| EPS (diluted) | -$0.82 | -$0.88 | -$0.82 | -$0.95 | -$0.94 | -$0.98 | -$0.71 | -$0.62 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$128.9M | -$153.1M | -$102.8M | -$194.5M | -$232.9M |
| Capital expenditure | -$1.6M | -$2.8M | -$34.5M | -$12.8M | -$1.4M |
| Free cash flow | -$130.5M | -$155.9M | -$137.3M | -$207.3M | -$234.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $243.1M | $149.8M | $0 | $596.6M | $992.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $691.0M
- Total assets
- $1.65B
- Total liabilities
- $139.9M
- Total debt
- $82.2M
- Net debt
- -$42.3M
- Shareholders’ equity
- $1.51B
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 10,530,809
- Days to cover
- 16.13
- Change vs previous report
- +1.5%
FINRA short interest, settlement date Sep 15, 2026.